A mutation in the gene of a glycolipid‐binding protein (GM2 activator) that causes GM2‐gangliosidosis variant AB
- 23 September 1991
- journal article
- Published by Wiley in FEBS Letters
- Vol. 290 (1-2) , 1-3
- https://doi.org/10.1016/0014-5793(91)81211-p
Abstract
GM2-gangliosidoses are neurological disorders caused by a genetic deficiency of either the β-hexosaminidase A or the GM2 activator, a glycolipid binding protein. In a patient with an immunologically proven GM2 activator protein deficiency, A T412 → C transition (counted from A of the initiation codon) was found in the coding sequence, which results in the substitution of Arg for the normal Cys107 in the mature GM2 activator protein. The remainder of the coding sequence remained entirely normal.Keywords
This publication has 6 references indexed in Scilit:
- Isolation of a cDNA encoding the human GM2 activator proteinFEBS Letters, 1989
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- Characterization of β-thalassaemia mutations using direct genomic sequencing of amplified single copy DNANature, 1987
- Molecular Forms of GM2-Activator Protein. A Study on its Biosynthesis in Human Skin FibroblastsBiological Chemistry Hoppe-Seyler, 1985
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- GM2-Gangliosidosis, AB variantActa Neuropathologica, 1975